Evaluation of therapeutic effectiveness of 131I-antiEGFR-BSA-PCL in a mouse model of colorectal cancer

doi:10.3748/wjg.v22.i14.3758

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8306)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series.

Item

Count

PDF

513

WORD

253

HTML

4371

Figures (1-7)

248

Sum=5385

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1047

Download

1874

Sum=2921

Apr 14, 2016 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Apr 14, 2016; 22(14): 3758-3768
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3758

Full Size Figure Download Figure

Figure 7 Histopathology of the liver, spleen, and tumor tissue at 3 d after the end of the treatment (× 100).

Citation: Li W, Ji YH, Li CX, Liu ZY, Li N, Fang L, Chang J, Tan J. Evaluation of therapeutic effectiveness of ¹³¹I-antiEGFR-BSA-PCL in a mouse model of colorectal cancer. World J Gastroenterol 2016; 22(14): 3758-3768
URL: https://www.wjgnet.com/1007-9327/full/v22/i14/3758.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i14.3758